Swiss healthtech focused private equity firm, MTIP has announced the closing of its MTIP Fund II at $250 million (€221m) in capital commitments.
The oversubscribed fund, which closed above its target of $225 million (€199m), continues its predecessor fund’s strategy of investing in growing and innovative healthtech companies primarily across Europe.
MTIP Fund II is a designated ‘dark green’ fund...
